Table 1 Baseline characteristics of 210 patients enrolled for the study
Characteristic | Â |
|---|---|
Male, n (%) | 170 (81) |
Age, years | 43 (20-68) |
Body mass index, kg/m2 | 24 (21-32) |
V iral Load | Â |
   -<400.000 UI/ml | 104(49) |
   ->400.000 UI/ml | 106(51) |
Route of Trasmission | Â |
   -Intravenous drug use | 142(68) |
   -Transfusion | 26(12) |
   - Unknown | 42(20) |
Alanine aminotransferase, IU/L | 147 (96-255) |
HCV genotype 2, n (%) | 116 (55) |
HCV genotype 3, n (%) | 94 (45) |
Cirrhosis (Ishak stage 5-6) n (%) | 21 (10) |
Bridging fibrosis (Ishak stage 3-4) n (%) | 41 (19) |